{
  "timestamp": "2026-01-05T07:10:13.997363",
  "agent_id": "medication_management",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "clarification_needed": false,
    "clarification_question": "",
    "suggested_answer": "",
    "medications": [
      {
        "name": "Sertraline",
        "generic_name": "Sertraline",
        "brand_name": "Zoloft",
        "strength": "50 mg",
        "form": "Tablet",
        "route": "PO",
        "frequency": "Daily",
        "indication": "*Major Depressive Disorder*",
        "response": "Poor (Symptoms persist after 4 weeks of treatment)",
        "adherence": "Adherent",
        "side_effects": []
      }
    ],
    "changes_made": [
      {
        "medication": "Sertraline",
        "change_type": "Increase Dose",
        "rationale": "Inadequate clinical response (persistent symptoms including anhedonia, early morning awakening, and suicidal ideation) after 4 weeks at 50mg. Dose titrated to 100mg daily to reach therapeutic level."
      }
    ],
    "peer_review_finding": {
      "status": "**MATCH**",
      "details": "*Sertraline* is a standard SSRI agent appropriate for the proposed diagnosis of **Recurrent Major Depressive Disorder (F33.1)**. No significant mismatch flagged."
    }
  },
  "duration_ms": 5575,
  "error": null
}